hydroxychloroquine has been researched along with Sarcoidosis in 54 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Four weeks prior, she had been initiated on hydroxychloroquine for a presumed diagnosis of cutaneous sarcoidosis." | 7.96 | Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. ( Ackerman, L; Brahmbhatt, S; Coleman, I; Ruiz, G, 2020) |
| "We report a case of orbital sarcoidosis with extraocular muscle and orbital fat involvement that did not respond to oral corticosteroid treatment, but was successfully treated with oral hydroxychloroquine." | 7.77 | Orbital sarcoidosis treated with hydroxychloroquine. ( Murchison, AP; Rabinowitz, MP, 2011) |
| "To assess the efficacy of chloroquine (Aralen) phosphate and hydroxychloroquine (Plaquenil) sulfate in the treatment of patients with neurosarcoidosis who either do not respond to corticosteroid therapy or develop unacceptable side effects." | 7.70 | Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. ( Sharma, OP, 1998) |
| "The 4-aminoquinolines, including chloroquine and hydroxychloroquine, have been successfully employed to treat patients with granuloma-forming disease-associated, vitamin D metabolite-mediated hypercalcemia." | 7.70 | Inability of short-term, low-dose hydroxychloroquine to resolve vitamin D-mediated hypercalcemia in patients with B-cell lymphoma. ( Adams, JS; Kantorovich, V, 1999) |
| " To avoid the use of systemic corticosteroids, we treated 17 patients with cutaneous sarcoidal granulomas with hydroxychloroquine (2 to 3 mg/kg/day) in an open clinical trial." | 7.68 | Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. ( Callen, JP; Jones, E, 1990) |
| "Sarcoidosis is a granulomatous multisystemic disease of unclear etiology, which can affect any organ." | 5.37 | [Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy]. ( Bertsch, HP; Meyersburg, D; Schön, MP; Seitz, CS, 2011) |
| "Hydroxychloroquine was administered as therapy for the hypercalcemia." | 5.27 | Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. ( Barré, PE; Gascon-Barré, M; Goltzman, D; Meakins, JL, 1987) |
| " Four weeks prior, she had been initiated on hydroxychloroquine for a presumed diagnosis of cutaneous sarcoidosis." | 3.96 | Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. ( Ackerman, L; Brahmbhatt, S; Coleman, I; Ruiz, G, 2020) |
| "We report a case of orbital sarcoidosis with extraocular muscle and orbital fat involvement that did not respond to oral corticosteroid treatment, but was successfully treated with oral hydroxychloroquine." | 3.77 | Orbital sarcoidosis treated with hydroxychloroquine. ( Murchison, AP; Rabinowitz, MP, 2011) |
| "To assess the efficacy of chloroquine (Aralen) phosphate and hydroxychloroquine (Plaquenil) sulfate in the treatment of patients with neurosarcoidosis who either do not respond to corticosteroid therapy or develop unacceptable side effects." | 3.70 | Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. ( Sharma, OP, 1998) |
| "The 4-aminoquinolines, including chloroquine and hydroxychloroquine, have been successfully employed to treat patients with granuloma-forming disease-associated, vitamin D metabolite-mediated hypercalcemia." | 3.70 | Inability of short-term, low-dose hydroxychloroquine to resolve vitamin D-mediated hypercalcemia in patients with B-cell lymphoma. ( Adams, JS; Kantorovich, V, 1999) |
| " To avoid the use of systemic corticosteroids, we treated 17 patients with cutaneous sarcoidal granulomas with hydroxychloroquine (2 to 3 mg/kg/day) in an open clinical trial." | 3.68 | Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. ( Callen, JP; Jones, E, 1990) |
| "In our patient, sarcoidosis developed after 3 years of continuous recombinant interferon-beta therapy, dosed 3 times a week." | 2.48 | Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review. ( Chakravarty, SD; Crow, MK; Harris, ME; Schreiner, AM, 2012) |
| "Sarcoidosis is a disease that exhibits extremely heterogeneous clinical manifestations." | 2.41 | Bone sarcoidosis. ( Bharadwaj, P; Sharma, OP; Wilcox, A, 2000) |
| "As sarcoidosis is a mimicking disease, a good differential diagnosis should be made to avoid misdiagnosis and in order not to be late in diagnosis and treatment." | 1.72 | Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience. ( Duruöz, MT; Esen, İ; Gezer, HH; Karabulut, Y; Öz, N, 2022) |
| "Sarcoidosis is a systemic condition characterized by formation of granulomas that can involve many organ systems, with the lungs and intrathoracic lymph nodes involved in more than 90% of cases." | 1.62 | Less Common Respiratory Conditions: Sarcoidosis. ( Falk, N; Garland, S; Wilk, A, 2021) |
| "Whereas cutaneous sarcoidosis is present in up to one-third of cases and may present with a wide variety of lesions, our presentation is uncommon." | 1.42 | Cutaneous sarcoidosis simulating porokeratosis of Mibelli. ( Benchikhi, H; Chiheb, S; Elfatoiki, FZ; Jabri, L; Soussi, W, 2015) |
| "Sarcoidosis is a chronic disease characterised by formation of non-calcified granulomas." | 1.42 | Co-occurrence of rheumatoid arthritis and sarcoidosis. ( Karaarslan, AA; Kobak, Ş; Sever, F; Yilmaz, H, 2015) |
| "Osseous sarcoidosis has been infrequently reported." | 1.40 | Osseous sarcoidosis: clinical characteristics, treatment, and outcomes--experience from a large, academic hospital. ( Aliabadi, P; Coblyn, JS; Fanta, CH; McSparron, JI; Paulson, V; Shah, N; Sparks, JA, 2014) |
| "Sarcoidosis is a systemic granulomatous disease that most commonly involves the lung and thoracic lymph nodes." | 1.39 | Phalangeal lytic lesion: do not forget osseous sarcoidosis. ( Ben Hassine, L; Cherif, E; Kechaou, I; Khalfallah, N, 2013) |
| "Sarcoidosis is multi organ disease with cutaneous manifestation in 20%-35% patients." | 1.38 | Unusual manifestation of cutaneous sarcoidosis: a case report of morpheaform sarcoidosis. ( Kalafi, A; Vasaghi, A, 2012) |
| "Sarcoidosis is a disease well known to dermatologists because of the frequency of cutaneous involvement." | 1.37 | [Gastric sarcoidosis revealed by cutaneous follicular sarcoidosis]. ( Bagot, M; Demongeot, C; Flageul, B; Georges, P; Moulonguet, I, 2011) |
| "Sarcoidosis is a granulomatous multisystemic disease of unclear etiology, which can affect any organ." | 1.37 | [Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy]. ( Bertsch, HP; Meyersburg, D; Schön, MP; Seitz, CS, 2011) |
| "Prednisone was used at a starting dose from about 0." | 1.33 | Muscle involvement in sarcoidosis: a retrospective and followup studies. ( Bardin, T; Berenbaum, F; Fayad, F; Lioté, F; Orcel, P, 2006) |
| "Hydroxychloroquine was administered as therapy for the hypercalcemia." | 1.27 | Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. ( Barré, PE; Gascon-Barré, M; Goltzman, D; Meakins, JL, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.41) | 18.7374 |
| 1990's | 9 (16.67) | 18.2507 |
| 2000's | 12 (22.22) | 29.6817 |
| 2010's | 19 (35.19) | 24.3611 |
| 2020's | 10 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Jamilloux, Y | 1 |
| El Jammal, T | 1 |
| Bert, A | 1 |
| Sève, P | 1 |
| Smedslund, G | 1 |
| Kotar, AM | 1 |
| Uhlig, T | 1 |
| Karabulut, Y | 1 |
| Öz, N | 1 |
| Gezer, HH | 1 |
| Esen, İ | 1 |
| Duruöz, MT | 1 |
| Sollors, J | 1 |
| Schlevogt, B | 1 |
| Schmidt, HJ | 1 |
| Woerns, MA | 1 |
| Galle, PR | 1 |
| Qian, Y | 1 |
| Antoni, C | 1 |
| Weis, CA | 1 |
| Hetjens, S | 1 |
| Bergner, R | 1 |
| Ebert, MP | 1 |
| Teufel, A | 1 |
| Györfi, AH | 1 |
| Kopp, M | 1 |
| May, M | 1 |
| Vetter, M | 1 |
| Uder, M | 1 |
| Kremer, AE | 1 |
| Schett, G | 1 |
| Harrer, T | 1 |
| Distler, JHW | 1 |
| Winthrop, KL | 1 |
| Brunton, AE | 1 |
| Beekmann, S | 1 |
| Polgreen, P | 1 |
| Baddley, J | 1 |
| Saag, KG | 1 |
| Calabrese, C | 1 |
| Calabrese, L | 1 |
| Robinson, PC | 1 |
| Wallace, ZS | 1 |
| Curtis, JR | 1 |
| Coleman, I | 1 |
| Ruiz, G | 1 |
| Brahmbhatt, S | 1 |
| Ackerman, L | 1 |
| Paolino, A | 1 |
| Galloway, J | 1 |
| Birring, S | 1 |
| Brex, P | 1 |
| Larkin, G | 1 |
| Patel, A | 1 |
| Sado, D | 1 |
| Murgatroyd, F | 1 |
| Walsh, S | 1 |
| Garland, S | 1 |
| Falk, N | 1 |
| Wilk, A | 1 |
| Thapa, SS | 1 |
| Sandhu, J | 1 |
| Sah, BP | 1 |
| Powell, E | 1 |
| Rosen, T | 2 |
| Raghu, G | 1 |
| Berman, JS | 1 |
| Govender, P | 1 |
| Rotenberg, C | 1 |
| Besnard, V | 1 |
| Brillet, PY | 1 |
| Giraudier, S | 1 |
| Nunes, H | 1 |
| Valeyre, D | 1 |
| Carey, B | 1 |
| Adegun, O | 1 |
| Hodgson, T | 1 |
| Ben Hassine, I | 1 |
| Rein, C | 1 |
| Comarmond, C | 1 |
| Glanowski, C | 1 |
| Saidenberg-Kermanac'h, N | 1 |
| Meunier, B | 1 |
| Schleinitz, N | 1 |
| Chanson, N | 1 |
| Sacré, K | 1 |
| Scherlinger, M | 1 |
| Richez, C | 1 |
| Hirschi, S | 1 |
| Groh, M | 1 |
| Devilliers, H | 1 |
| Bielefeld, P | 1 |
| Saadoun, D | 1 |
| Chapelon-Abric, C | 1 |
| Arnaud, L | 1 |
| Cacoub, P | 1 |
| Cherif, E | 1 |
| Ben Hassine, L | 1 |
| Kechaou, I | 1 |
| Khalfallah, N | 1 |
| Marchetti, M | 1 |
| Baker, MG | 1 |
| Noland, MM | 1 |
| Sparks, JA | 1 |
| McSparron, JI | 1 |
| Shah, N | 1 |
| Aliabadi, P | 1 |
| Paulson, V | 1 |
| Fanta, CH | 1 |
| Coblyn, JS | 1 |
| Elfatoiki, FZ | 1 |
| Soussi, W | 1 |
| Chiheb, S | 1 |
| Jabri, L | 1 |
| Benchikhi, H | 1 |
| Kobak, Ş | 1 |
| Karaarslan, AA | 1 |
| Yilmaz, H | 1 |
| Sever, F | 1 |
| Yachoui, R | 1 |
| Parker, BJ | 1 |
| Nguyen, TT | 1 |
| Mevius, H | 1 |
| Quax, RA | 1 |
| Alsma, J | 1 |
| Kowalczyk, JP | 1 |
| Ricotti, CA | 1 |
| de Araujo, T | 1 |
| Drosou, A | 1 |
| Nousari, CH | 1 |
| Rabinowitz, MP | 1 |
| Murchison, AP | 1 |
| Demongeot, C | 1 |
| Moulonguet, I | 1 |
| Georges, P | 1 |
| Bagot, M | 1 |
| Flageul, B | 1 |
| Meyersburg, D | 1 |
| Schön, MP | 1 |
| Bertsch, HP | 1 |
| Seitz, CS | 1 |
| Mankia, KS | 1 |
| David, J | 1 |
| Chakravarty, SD | 1 |
| Harris, ME | 1 |
| Schreiner, AM | 1 |
| Crow, MK | 1 |
| Vasaghi, A | 1 |
| Kalafi, A | 1 |
| Gorovoy, I | 1 |
| Gorovoy, JB | 1 |
| Ingster-Moati, I | 1 |
| Crochet, M | 1 |
| Manchon, E | 1 |
| Anquetil, D | 1 |
| Lestrade, C | 1 |
| Jacob, A | 1 |
| Le Brun, D | 1 |
| Albuisson, E | 1 |
| Lowry, TR | 1 |
| Fayad, F | 1 |
| Lioté, F | 1 |
| Berenbaum, F | 1 |
| Orcel, P | 1 |
| Bardin, T | 1 |
| Ginarte, M | 1 |
| Zulaica, A | 1 |
| Toribio, J | 1 |
| Modi, S | 1 |
| Patel, KB | 1 |
| Sharma, OP | 5 |
| Joundy, N | 1 |
| Carpentier, S | 1 |
| Leclech, C | 1 |
| Aubé, C | 1 |
| Rousselet, MC | 1 |
| Barré, P | 1 |
| Oberti, F | 1 |
| Calès, P | 1 |
| Wallace, DJ | 1 |
| Sinha, RN | 1 |
| Fraser, WD | 1 |
| Casson, IF | 1 |
| Hassid, S | 1 |
| Choufani, G | 1 |
| Saussez, S | 1 |
| Dubois, M | 1 |
| Salmon, I | 1 |
| Soupart, A | 1 |
| Marvisi, M | 1 |
| Adams, JS | 1 |
| Kantorovich, V | 1 |
| Carriere, M | 1 |
| Loche, F | 1 |
| Schwarze, HP | 1 |
| Bouissou, X | 1 |
| Laplanche, G | 1 |
| Bazex, J | 1 |
| Wilcox, A | 1 |
| Bharadwaj, P | 1 |
| Shimoni, A | 1 |
| Hershcovici, T | 1 |
| Mekhmandarov, S | 1 |
| Maor-Kendler, Y | 1 |
| Beigel, Y | 1 |
| Burdick, AE | 1 |
| Hendi, A | 1 |
| Elgart, GW | 1 |
| Barquin, L | 1 |
| Scollard, DM | 1 |
| Granel, B | 1 |
| Gaudy, C | 1 |
| Serratrice, J | 1 |
| de Roux-Serratrice, C | 1 |
| Félician, O | 1 |
| Swiader, L | 1 |
| Pache, X | 1 |
| Ceccaldi, M | 1 |
| Balzamo, M | 1 |
| Donnet, A | 1 |
| Manera, L | 1 |
| Raybaud, C | 1 |
| Disdier, P | 1 |
| Weiller, PJ | 1 |
| Allanore, Y | 1 |
| Perrot, S | 1 |
| Menkès, CJ | 1 |
| Kahan, A | 1 |
| Jones, E | 1 |
| Callen, JP | 1 |
| DeSimone, DP | 1 |
| Brilliant, HL | 1 |
| Basile, J | 1 |
| Bell, NH | 1 |
| Barré, PE | 1 |
| Gascon-Barré, M | 1 |
| Meakins, JL | 1 |
| Goltzman, D | 1 |
| Verdegem, TD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells[NCT04751279] | 80 participants (Anticipated) | Observational | 2021-03-09 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for hydroxychloroquine and Sarcoidosis
| Article | Year |
|---|---|
[Hydroxychloroquine for non-severe extra-pulmonary sarcoidosis].
Topics: Adrenal Cortex Hormones; Humans; Hydroxychloroquine; Sarcoidosis; Sarcoidosis, Pulmonary; Steroids | 2022 |
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Hydroxychlor | 2022 |
Treatment of Sarcoidosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppress | 2018 |
Bone and bone marrow involvement in sarcoidosis.
Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glu | 2015 |
Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Interferon-beta; Methotrexate; | 2012 |
The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
Topics: Antimalarials; Antiphospholipid Syndrome; Autoimmune Diseases; Chloroquine; Controlled Clinical Tria | 1996 |
[Osteoarticular sarcoidosis].
Topics: Adrenal Cortex Hormones; Adult; Analgesics; Antirheumatic Agents; Biopsy; Bone Diseases; Child; Chlo | 1998 |
Bone sarcoidosis.
Topics: Antimalarials; Bone Diseases; Chloroquine; Female; Glucocorticoids; Granuloma; Humans; Hydroxychloro | 2000 |
46 other studies available for hydroxychloroquine and Sarcoidosis
| Article | Year |
|---|---|
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
Topics: Adrenal Cortex Hormones; Ambulatory Care Facilities; Anti-Inflammatory Agents, Non-Steroidal; Arthri | 2022 |
Management of Hepatic Sarcoidosis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Digestive System Diseases; Humans; Hydroxychlo | 2022 |
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis.
Topics: Chronic Disease; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Recurrence; Sarcoidosis | 2021 |
SARS CoV-2 infection among patients using immunomodulatory therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized | 2021 |
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Antimalarials; Biopsy; Coronavirus Infections; COV | 2020 |
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; | 2021 |
Less Common Respiratory Conditions: Sarcoidosis.
Topics: Biopsy; Humans; Hydroxychloroquine; Lung; Sarcoidosis; Sarcoidosis, Pulmonary | 2021 |
An Uncommon Cause of Severe Hypercalcemia: Vitamin D Supplementation in Sarcoidosis.
Topics: Adult; Antirheumatic Agents; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Glucocorticoids; H | 2021 |
Ulcerative sarcoidosis: a prototypical presentation and review.
Topics: Anti-Inflammatory Agents; Humans; Hydroxychloroquine; Leg Ulcer; Long-Term Care; Male; Middle Aged; | 2017 |
Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.
Topics: Adrenal Cortex Hormones; Biopsy; Female; Humans; Hydroxychloroquine; Janus Kinase 2; Middle Aged; Mu | 2018 |
A lump on the palate.
Topics: Antirheumatic Agents; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Granu | 2019 |
Osseous sarcoidosis: A multicenter retrospective case-control study of 48 patients.
Topics: Adult; Biopsy, Needle; Bone Diseases; Case-Control Studies; Drug Therapy, Combination; Female; Franc | 2019 |
Phalangeal lytic lesion: do not forget osseous sarcoidosis.
Topics: Aged; Antirheumatic Agents; Bone Diseases; Diagnosis, Differential; Female; Finger Phalanges; Humans | 2013 |
Treatment of subcutaneous sarcoidosis with hydroxychloroquine: report of 2 cases.
Topics: Adrenal Cortex Hormones; Biopsy; Contraindications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Ty | 2014 |
Osseous sarcoidosis: clinical characteristics, treatment, and outcomes--experience from a large, academic hospital.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Bone and Bones; Bone Diseases; | 2014 |
Cutaneous sarcoidosis simulating porokeratosis of Mibelli.
Topics: Anti-Inflammatory Agents; Biopsy; Humans; Hydroxychloroquine; Male; Middle Aged; Porokeratosis; Pred | 2015 |
Co-occurrence of rheumatoid arthritis and sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Ankle Joint; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Fo | 2015 |
Man With Necrotizing Ulcers on the Leg.
Topics: Adult; Enzyme Inhibitors; Glucocorticoids; Humans; Hydroxychloroquine; Leg Ulcer; Male; Sarcoidosis; | 2016 |
"Strawberry gums" in sarcoidosis.
Topics: Adult; Antibodies, Monoclonal; Eye Diseases; Female; Gingival Hyperplasia; Humans; Hydroxychloroquin | 2008 |
Orbital sarcoidosis treated with hydroxychloroquine.
Topics: Antirheumatic Agents; Biopsy; Glucocorticoids; Humans; Hydroxychloroquine; Male; Middle Aged; Orbita | 2011 |
[Gastric sarcoidosis revealed by cutaneous follicular sarcoidosis].
Topics: Antimalarials; Arthritis; Biopsy; Female; Folliculitis; Gastric Mucosa; Gastroscopy; Giant Cells; Ha | 2011 |
[Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy].
Topics: Antirheumatic Agents; Biopsy; Combined Modality Therapy; Debridement; Diagnosis, Differential; Femal | 2011 |
A diagnosis of sarcoid arthritis: 'check the tattoos'.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis; Drug Therapy, Combination; Humans; | 2011 |
Unusual manifestation of cutaneous sarcoidosis: a case report of morpheaform sarcoidosis.
Topics: Adolescent; Biopsy; Humans; Hydroxychloroquine; Male; Prednisolone; Sarcoidosis; Skin Diseases | 2012 |
Advances in ophthalmic monitoring for hydroxychloroquine toxicity.
Topics: Antirheumatic Agents; Diagnostic Techniques, Ophthalmological; Dose-Response Relationship, Drug; Dru | 2013 |
[Analysis of 925 patients on long-term hydroxychloroquine or chloroquine treatment: results of ophthalmological screening].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Female; Humans; Hydroxychloroquine; Lupus | 2004 |
Sarcoidosis of nasal ala and lower lip.
Topics: Adult; Biopsy; Dermatologic Agents; Humans; Hydroxychloroquine; Male; Mouth Diseases; Nose Diseases; | 2004 |
Muscle involvement in sarcoidosis: a retrospective and followup studies.
Topics: Adult; Cardiomyopathies; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studie | 2006 |
Morpheaform sarcoidosis.
Topics: Aged; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Humans; Hydroxychloro | 2006 |
Micropapular cutaneous sarcoidosis: case series successfully managed with hydroxychloroquine sulfate.
Topics: Adult; Antirheumatic Agents; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Male; Recu | 2008 |
Nails in sarcoidosis: response to treatment.
Topics: Female; Humans; Hydroxychloroquine; Middle Aged; Nail Diseases; Prednisone; Sarcoidosis | 1983 |
[Favourable course of a pseudotumoral form of hepatic and splenic sarcoidosis under treatment with hydroxychloroquine and colchicine].
Topics: Antimalarials; Colchicine; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Hydroxychlo | 1995 |
Long-term management of hypercalcaemia in chronically active sarcoidosis.
Topics: Adult; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Hy | 1997 |
Neurosarcoidosis: a personal perspective based on the study of 37 patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Biopsy; Central Nervous System Diseases; Child; Chloroquine; D | 1997 |
Sarcoidosis of the paranasal sinuses treated with hydroxychloroquine.
Topics: Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Middle Aged; Paranasal Sinus Diseases; P | 1998 |
Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.
Topics: Adult; Antimalarials; Brain; Chloroquine; Female; Humans; Hydroxychloroquine; Magnetic Resonance Ima | 1998 |
Inability of short-term, low-dose hydroxychloroquine to resolve vitamin D-mediated hypercalcemia in patients with B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cyclophosphamide; Doxorubic | 1999 |
Sarcoid panniculitis.
Topics: Humans; Hydroxychloroquine; Male; Middle Aged; Panniculitis; Sarcoidosis; Sarcoidosis, Pulmonary | 2000 |
Skeletal sarcoidosis: successful treatment with hydroxychloroquine.
Topics: Antimalarials; Bone Diseases; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Middle | 2000 |
Hansen's disease in a patient with a history of sarcoidosis.
Topics: Anti-Inflammatory Agents; Biopsy; Clofazimine; Dapsone; Dermatologic Agents; Electromyography; Femal | 2000 |
[Psychological and behavioral disorders with good outcome in neurosarcoidosis].
Topics: Adult; Antirheumatic Agents; Cognition Disorders; Drug Therapy, Combination; Facial Paralysis; Femal | 2001 |
Management of a patient with sarcoid calcaneitis and dactylitis.
Topics: Adult; Antirheumatic Agents; Calcaneus; Drug Therapy, Combination; Finger Joint; Glucocorticoids; Hu | 2001 |
Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas.
Topics: Adult; Aged; Female; Follow-Up Studies; Granuloma; Humans; Hydroxychloroquine; Male; Middle Aged; Sa | 1990 |
Granulomatous infiltration of the talus and abnormal vitamin D and calcium metabolism in a patient with sarcoidosis: successful treatment with hydroxychloroquine.
Topics: Bone Diseases; Bone Marrow Diseases; Calcitriol; Calcium; Female; Humans; Hydroxychloroquine; Magnet | 1989 |
Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis.
Topics: Female; Humans; Hydroxychloroquine; Hydroxycholecalciferols; Hypercalcemia; Kidney Failure, Chronic; | 1987 |
Cutaneous ulcers in sarcoidosis.
Topics: Adult; Chloroquine; Female; Humans; Hydroxychloroquine; Middle Aged; Prednisone; Sarcoidosis; Skin; | 1987 |